Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer

Alexandrakis MG, 2003, Am J Clin Oncol, 26, 135, 10.1097/00000421-200304000-00007

Ali AA, 2004, Eur J Surg Oncol, 30, 292, 10.1016/j.ejso.2003.11.018

10.1016/j.amjsurg.2009.08.041

10.1007/s00384-010-1052-0

Dolcetti R, 1999, Am J Pathol, 154, 1805, 10.1016/S0002-9440(10)65436-3

Dutta S, 2011, World J Surg, 35, 1861, 10.1007/s00268-011-1130-7

Eaden JA, 2001, Gut, 48, 526, 10.1136/gut.48.4.526

Graf W, 1994, Eur J Cancer, 30, 453, 10.1016/0959-8049(94)90417-0

Halazun KJ, 2008, Eur J Surg Oncol, 34, 55, 10.1016/j.ejso.2007.02.014

Hauser CA, 2006, Support Care Cancer, 14, 999, 10.1007/s00520-006-0079-9

10.1007/BF02573067

Ishizuka M, 2009, Ann Surg, 250, 268, 10.1097/SLA.0b013e3181b16e24

Jung KW, 2011, Cancer Res Treat, 43, 1, 10.4143/crt.2011.43.1.1

Klinger MH, 2002, J Interferon Cytokine Res, 22, 913, 10.1089/10799900260286623

10.1023/B:AGEN.0000029415.62384.ba

Kwon KA, 2010, BMC Cancer, 10, 203, 10.1186/1471-2407-10-203

10.1245/s10434-006-9322-3

Lord BI, 1989, Proc Natl Acad Sci USA, 86, 9499, 10.1073/pnas.86.23.9499

MacDonald N, 2007, J Support Oncol, 5

Maltoni M, 2005, J Clin Oncol, 23, 6240, 10.1200/JCO.2005.06.866

McMillan DC, 1995, Am J Surg, 170, 319, 10.1016/S0002-9610(99)80296-7

Menges T, 1999, Crit Care Med, 27, 733, 10.1097/00003246-199904000-00026

Nagtegaal ID, 2001, BMC Cancer, 1, 7, 10.1186/1471-2407-1-7

Pritchard CC, 2011, Gut, 60, 116, 10.1136/gut.2009.206250

Roxburgh CS, 2010, Future Oncol, 6, 149, 10.2217/fon.09.136

Roxburgh CS, 2009, Ann Surg, 249, 788, 10.1097/SLA.0b013e3181a3e738

10.1016/j.cytogfr.2007.01.015

Scott HR, 2002, Br J Cancer, 87, 264, 10.1038/sj.bjc.6600466

Sierko E, 2004, Semin Thromb Hemost, 30, 95, 10.1055/s-2004-822974

Ulich TR, 1987, J Immunol, 139, 3406, 10.4049/jimmunol.139.10.3406

10.1002/jso.20329